FI943100A - Ansamysiinijohdannaisia antionkogeenisina ja syövänvastaisina aineina - Google Patents

Ansamysiinijohdannaisia antionkogeenisina ja syövänvastaisina aineina Download PDF

Info

Publication number
FI943100A
FI943100A FI943100A FI943100A FI943100A FI 943100 A FI943100 A FI 943100A FI 943100 A FI943100 A FI 943100A FI 943100 A FI943100 A FI 943100A FI 943100 A FI943100 A FI 943100A
Authority
FI
Finland
Prior art keywords
anthionogenic
cancer agents
ansamycin derivatives
ansamycin
derivatives
Prior art date
Application number
FI943100A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI943100A0 (fi
Inventor
Randall James Gallaschun
Mikel Paul Moyer
Rodney Caughren Schnur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI943100A0 publication Critical patent/FI943100A0/fi
Publication of FI943100A publication Critical patent/FI943100A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D225/00Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI943100A 1993-06-29 1994-06-28 Ansamysiinijohdannaisia antionkogeenisina ja syövänvastaisina aineina FI943100A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8506593A 1993-06-29 1993-06-29

Publications (2)

Publication Number Publication Date
FI943100A0 FI943100A0 (fi) 1994-06-28
FI943100A true FI943100A (fi) 1994-12-30

Family

ID=22189242

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943100A FI943100A (fi) 1993-06-29 1994-06-28 Ansamysiinijohdannaisia antionkogeenisina ja syövänvastaisina aineina

Country Status (5)

Country Link
EP (1) EP0706516A1 (fr)
JP (1) JP2794342B2 (fr)
CA (1) CA2166320A1 (fr)
FI (1) FI943100A (fr)
WO (1) WO1995001342A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2338000C (fr) 1998-07-17 2009-12-15 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Derives 4-thiomaleimidiques solubles dans l'eau et methodes pour les produire
CA2370007A1 (fr) * 1999-04-09 2000-10-19 Sloan-Kettering Institute For Cancer Research Procedes et compositions permettant la degradation et/ou l'inhibition des tyrosine kinases appartenant a la famille her
AU2002217866A1 (en) * 2000-11-06 2002-05-15 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Geldanamycin derivatives useful for the treatment of cancer
IL156122A0 (en) * 2001-03-30 2003-12-23 Nasa Geldanamycin derivative and method of treating cancer using same
WO2003013430A2 (fr) * 2001-08-06 2003-02-20 Kosan Biosciences, Inc. Ansamycine benzoquinone
EP1435939B1 (fr) * 2001-09-24 2008-02-27 Conforma Therapeutic Corporation Procede de preparation de 17-allyl amino geldanamycine (17-aag) et d'autres ansamycines
EP1923061A1 (fr) 2001-09-24 2008-05-21 Conforma Therapeutic Corporation Procédé pour la préparation de 17-allyl amino geldanamycine (17-AAG) et autres ansamycines
DE60327994D1 (de) 2002-02-08 2009-07-30 Conforma Therapeutics Corp Ansamycine mit verbesserten pharmakologischen und biologischen eigenschaften
JP2006514994A (ja) * 2003-03-13 2006-05-18 コンフォーマ・セラピューティクス・コーポレイション 長鎖および中鎖トリグリセリドを有する医薬製剤
US6875863B1 (en) 2003-11-12 2005-04-05 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
US6887993B1 (en) 2003-11-12 2005-05-03 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
CA2545457A1 (fr) 2003-11-12 2005-06-23 Kosan Biosciences, Inc. Composes 11-o-methylgeldanamycine
US6855705B1 (en) 2003-11-12 2005-02-15 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
US20060019941A1 (en) * 2003-12-23 2006-01-26 Infinity Pharmaceuticals, Inc. Analogs of benzoquinone-containing ansamycins and methods of use thereof
JP4869077B2 (ja) 2003-12-23 2012-02-01 インフィニティー ディスカヴァリー インコーポレイテッド 癌治療に使用するベンゾキノン包含アンサマイシン類のアナログ
PE20081506A1 (es) 2006-12-12 2008-12-09 Infinity Discovery Inc Formulaciones de ansamicina
WO2010045442A1 (fr) 2008-10-15 2010-04-22 Infinity Discovery, Inc. Compositions d'ansamycine hydroquinone

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3595955A (en) * 1969-03-26 1971-07-27 Upjohn Co Geldanamycin and process for producing same
US3987035A (en) * 1974-04-05 1976-10-19 University Of Illinois Foundation Biologically active compounds
US4261989A (en) * 1979-02-19 1981-04-14 Kaken Chemical Co. Ltd. Geldanamycin derivatives and antitumor drug
HU9401936D0 (en) * 1992-01-06 1994-09-28 Pfizer Process and uses for 4,5-diohydrogeldanamycin and its hydroquinone

Also Published As

Publication number Publication date
WO1995001342A1 (fr) 1995-01-12
FI943100A0 (fi) 1994-06-28
EP0706516A1 (fr) 1996-04-17
CA2166320A1 (fr) 1995-01-12
JP2794342B2 (ja) 1998-09-03
JPH08506356A (ja) 1996-07-09

Similar Documents

Publication Publication Date Title
FI961599A (fi) 1N-alkyyli-N-aryylipyrimidiiniamiineja ja niiden johdannaisia
ATE162199T1 (de) Androstenderivate
FI941137A (fi) 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi
EE9700190A (et) Pürasool-4-üül-bensoüüli derivaadid ja nende kasutamine herbitsiididena
FI944310A0 (fi) Heteroaryyliamino- ja heteroaryylisuolfonamidosubstituoituja 3-bentsyyliaminometyylipiperidiinejä ja vastaavia yhdisteitä
FI953479A0 (fi) 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö
ATA75293A (de) Indolderivate
FI943100A (fi) Ansamysiinijohdannaisia antionkogeenisina ja syövänvastaisina aineina
ITMI920408A1 (it) Derivati benzopiranici e benzotiopiranici
DE69330497D1 (de) Chinazolin-derivate
FI960867A (fi) Bentsatsepiinijohdannainen, sen farmaseuttinen seos ja välituote
DE59308714D1 (de) Cyclobutan-benzol-derivate
FI953021A0 (fi) 4-bentsoyyli-isoksatsolin johdannaisia ja niiden käyttö herbisideinä
FI960076A (fi) Uudet (1-heteroatsolyyli-1-heterosyklyyli) alkaanijohdannaiset ja niiden käyttö hermostoa suojaavina aineina
FI955679A0 (fi) Piperidiinijohdannaisia, niiden valmistus ja käyttö
BR9408029A (pt) Derivados de 3-azabicicloalcanos N-substituídos
NO952288D0 (no) Benzazepinon-derivater
DE69313890D1 (de) 5-Aminoflavon-Derivate
EE03614B1 (et) Pürasool-4-üül-bensoüüli derivaadid ja nende kasutamine herbitsiididena
FI943513A0 (fi) Kolekystokiniiniantagonisteina käyttökelpoisia 3-fenyyliureidoatsepin-2-oneja ja -bentsatsepin-2-oneja
DE59407726D1 (de) 3-Aryl-4-hydroxy-3-dihydrofuranon-Derivate
ITMI941191A0 (it) 1-b-metil-2-tiol carbapen derivati
FI950303A (fi) Pyridoindolobentsodiatsepiinit ja johdannaiset antipsykoottisina aineina
DE69400388D1 (de) Cyclohexendiolderivate
NO934473D0 (no) N-substituerte azabicykloheptanderivater